Hi Reddit!
We’re a panel of Johns Hopkins faculty from the Schools of Public Health and Medicine, and we run the Novel Coronavirus Research Compendium (NCRC). We rapidly curate and review research preprints and articles about SARS-CoV-2 and COVID-19. We screen every article that comes through PubMed, SSRN, medRxiv, and bioRxiv. Our goal is to flag key evidence for frontline public health practitioners, clinicians, and policy makers so that they can respond to the pandemic effectively. Occasionally, we post reviews about controversial articles that are receiving a lot of media attention.
The NCRC has eight teams, each with a different expertise. We can answer your questions about anything in those topic areas: vaccines, diagnostics, disease modeling, epidemiology, pharmaceutical interventions, clinical presentation and risk factors that affect disease severity, ecology and spillover, and non-pharmaceutical interventions (e.g., contact tracing, masks, school closures, policy evaluations).
Science is constantly evolving, but we do have a firm understanding of some things. Today we want to take this opportunity to engage with the public and share what we’ve learned so far. We are pleased to be hosting this panel to talk about the COVID-19 pandemic and are glad that you’re here!
We'll be answering questions starting at 12:00 PM (US Eastern), with more panelists joining at 1:00 PM! EDIT: Our panelists had a little bit of a late start but as of 12:20 they're hard at work writing up answers and will be coming in any minute now :)
We are:
Emily S. Gurley, PhD (bio) co-leads the NCRC and is an associate scientist in the Department of Epidemiology at the Bloomberg School of Public Health (BSPH). She is a specialist in infectious disease epidemiology, disease surveillance and outbreaks, and One Health (which includes disease spillover from animals to humans). She co-leads the epidemiology and ecology teams.
Kate Grabowski, PhD (bio) co-leads the NCRC and is an assistant professor in the Division of Infectious at the School of Medicine (SOM) and BSPH Department of Epidemiology. She is a specialist in transmission dynamics, viral phylogenetics, and network epidemiology. She co-leads the non-pharmaceutical and pharmaceutical interventions teams.
Elizabeth A. Stuart, PhD ([bio](https://www.jhsph.e
... keep reading on reddit ➡Hey CompTIA family,
A few weeks ago I developed a new startup idea (DojoLab), a learn by doing platform, which is focusing exclusively on performance-based questions and IT labs. All the labs are following IT certification curriculums. (at this point in time, only CompTIA).
I'm posting a free sample for you to explore the platform with a hope of receiving feedback on what you like or what you don't.
Moreover, I would be happy to know which exam curriculum you want to add in the future.
- Constantine
